Platelet Rich Plasma has emerged as a convenient treatment method for fast recovery of medical conditions. The concentrated plasma is obtained through simple centrifugal operation on human blood to separate plasma from that of other blood components. Rising number of orthopedic disorders, increasing number of cosmetic surgeries and growing adoption of plasma therapy in developing economies are the key attributes toward the growth of the global platelet rich plasma market. According to the data published by the American Society of Plastic Surgeons, in 2018, approximately 17.7 million cosmetic procedures, up 2.0% than 2017, were performed in the United States alone. Along with the United States, these surgical procedures are increasing at a prominent rate in other geographies such as Asia Pacific and is anticipated to offer significant opportunities for platelet rich plasms during the forecast period.
The report titled “Platelet Rich Plasma Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global platelet rich plasma market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, , research & development activities, product portfolio, employee strength, and key executive, for all the major players operating in the market. For instance, Zimmer Biomet reported revenues of US$ 7,933 million in 2018 and the product segment analysis of the company indicates that Knees product category or business segment of the company dominated revenue in 2018 with the Americas being the major revenue generating geography.
The global platelet rich plasma (PRP) market is segmented based on product type, origin, application, and geography. Based on product type, the global platelet rich plasma market is segmented into pure PRP, leukocyte rich PRP, and leukocyte rich fibrin. Based on origin, the global platelet rich plasma market is segmented into autologous platelet rich plasma, allogeneic platelet rich plasma, and homologous platelet rich plasma. Based on application, the global platelet rich plasma market is segmented into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, and others. Based on geography, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Additionally, the study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the platelet rich plasma and associated products manufacturers. Further, market share of prominent companies in the global platelet rich plasma market would also be estimated. For instance, Zimmer Biome operates through six business divisions namely Knees, Hips, S.E.T., Spine & CFM, Dental, and others. The platelet rich plasmas are delivered under S.E.T. business division of the company with revenue contribution of US$ 1,752 Million in 2018.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the platelet rich plasma companies. Furthermore, the global platelet rich plasma market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the platelet rich plasma business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global platelet rich plasma market arena.
Major players operating the global platelet rich plasma market include AdiStem Ltd., Arthrex, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., Exactech Inc., Harvest Technologies Corporation, ISTO Biologics, Nuo Therapeutics, Stryker Corporation, and Zimmer Biomet.
InsightSLICE adopts a research methodology which is highly meticulous and comprehensive, yielding accurate research results. Our research methodology utilizes data triangulation model which helps in the precise collection and validation of information. Our set processes for problem solving and paid primary tools guarantee that any client requirement is met with utmost diligence and accuracy. Some of the primary components that are consequential to our research approach are:
Secondary Research or Desk Research
Distinctive Data Model
Secondary Sources include but are not limited to:
Past Published Research
Historical Data and Information
Primary Sources include but are not limited to:
InsightSLICE also leverages three types of data triangulation approaches as follows:
Data Source Triangulation
Extracting data and validation from multiple type of secondary and primary sources
Combining various methodologies to validate data inputs
Applying different theories to check credibility of data sets